Zhou Rui, Zhou Xiaoshu, Yin Zhongyuan, Guo Jing, Hu Ting, Jiang Shun, Liu Li, Dong Xiaorong, Zhang Sheng, Wu Gang
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.
Department of Oncology of the Affiliated Hospital of Qingdao University, Qingdao, China.
Sci Rep. 2016 Oct 20;6:35714. doi: 10.1038/srep35714.
Dysregulation of microRNAs (miRNAs) has been associated with malignant behavior in a variety of cancers. Our previous study demonstrated that miRNA expression profiles are predictors for patients with advanced non-small cell lung cancer (NSCLC). We also showed that miRNAs are involved in small-cell lung cancer metastasis. Here, we used qRT-PCR to re-analyze our previous microarray results using serum samples from 75 patients with NSCLC. Surprisingly, we found that miR-574-5p and miR-874 were overexpressed in patients with metastatic advanced NSCLC but not in patients with non-metastatic advanced NSCLC. Additionally, miR-574-5p expression was correlated between matched serum and tissue samples from 68 patients. However, these 2 miRNAs are not prognostic factors for NSCLC. Transwell and wound-healing assays showed that miR-574-5p promotes the migration and invasion of NSCLC cells. Furthermore, miR-574-5p enhanced the tyrosine phosphorylation of β-catenin by repressing PTPRU expression in vitro. In conclusion, this study explored the expression of miR-574-5p in clinical samples and its molecular mechanisms in the metastasis of advanced NSCLC.
微小RNA(miRNA)失调与多种癌症的恶性行为相关。我们之前的研究表明,miRNA表达谱可作为晚期非小细胞肺癌(NSCLC)患者的预测指标。我们还发现miRNA参与小细胞肺癌转移。在此,我们使用qRT-PCR对之前的微阵列结果进行重新分析,所用血清样本来自75例NSCLC患者。令人惊讶的是,我们发现miR-574-5p和miR-874在转移性晚期NSCLC患者中过表达,而在非转移性晚期NSCLC患者中未过表达。此外,68例患者匹配的血清和组织样本之间miR-574-5p表达具有相关性。然而,这两种miRNA并非NSCLC的预后因素。Transwell和伤口愈合实验表明,miR-574-5p促进NSCLC细胞的迁移和侵袭。此外,在体外miR-574-5p通过抑制PTPRU表达增强β-连环蛋白的酪氨酸磷酸化。总之,本研究探讨了miR-574-5p在临床样本中的表达及其在晚期NSCLC转移中的分子机制。